None
Quote | Protalix BioTherapeutics Inc. (NYSE:PLX)
Last: | $1.26 |
---|---|
Change Percent: | 0.8% |
Open: | $1.24 |
Close: | $1.26 |
High: | $1.28 |
Low: | $1.24 |
Volume: | 281,402 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Protalix BioTherapeutics Inc. (NYSE:PLX)
2024-03-14 13:02:10 ET Protalix BioTherapeutics, Inc. (PLX) Q4 2023 Earnings Conference Call March 14, 2024 08:30 ET Company Participants Lauren Merrick - Investor Relations Dror Bashan - President and Chief Executive Officer Eyal Rubin - Senior Vice President an...
2024-03-14 06:51:52 ET More on Protalix BioTherapeutics Seeking Alpha’s Quant Rating on Protalix BioTherapeutics Historical earnings data for Protalix BioTherapeutics Financial information for Protalix BioTherapeutics Read the full article on Seeking...
Message Board Posts | Protalix BioTherapeutics Inc. (NYSE:PLX)
Subject | By | Source | When |
---|---|---|---|
Most of the payments must be tied to | king oil | investorshub | 05/19/2023 12:37:06 AM |
I remotely recall that Chiesi paid of some | midastouch017 | investorshub | 05/18/2023 4:08:44 PM |
Well that explains the stock plummeting after approval. | king oil | investorshub | 05/18/2023 3:44:12 PM |
On a proforma basis, including the receipt of | midastouch017 | investorshub | 05/18/2023 12:46:17 PM |
Protalix BioTherapeutics Announces $20 Million Milestone Payment from | midastouch017 | investorshub | 05/18/2023 12:40:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Protalix BioTherapeutics Inc. Company Name:
PLX Stock Symbol:
NYSE Market:
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results PR Newswire Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , March 14, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE Ameri...
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 PR Newswire Company to host conference call and webcast at 8:30 a.m. EDT CARMIEL, Israel , March 7, 2024 /PRNewswire/ -- Protalix BioTherapeutics, I...
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference PR Newswire Corporate presentation scheduled for Monday, February 26, 2024 at 1:00 PM ET ...